Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02663518
Recruitment Status : Recruiting
First Posted : January 26, 2016
Last Update Posted : September 1, 2021
Sponsor:
Information provided by (Responsible Party):
Trillium Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021